Bank of New York Mellon’s Psychemedics Corporation PMD Stock Holding History

Bank of New York Mellon’s Portfolio PMD Stock Details PMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-11,074	Closed	-$61K	–	4159
2020 Q2	$61K	Hold	11,074	–	–	﹤0.01%	3959
2020 Q1	$67K	Buy	11,074 +1	+0%	+$8	﹤0.01%	3923
2019 Q4	$101K	Hold	11,073	–	–	﹤0.01%	4023
2019 Q3	$101K	Hold	11,073	–	–	﹤0.01%	4025
2019 Q2	$112K	Hold	11,073	–	–	﹤0.01%	4013
2019 Q1	$156K	Sell	11,073 -164	-1%	-$2.82K	﹤0.01%	3932
2018 Q4	$178K	Sell	11,237 -28,887	-72%	-$498K	﹤0.01%	3871
2018 Q3	$755K	Buy	40,124 +1,125	+3%	+$22.4K	﹤0.01%	3422
2018 Q2	$750K	Sell	38,999 -1,219	-3%	-$24.7K	﹤0.01%	3408
2018 Q1	$859K	Buy	40,218 +1,012	+3%	+$21K	﹤0.01%	3298
2017 Q4	$806K	Buy	39,206 +27,968	+249%	+$519K	﹤0.01%	3370
2017 Q3	$207K	Buy	+11,238	New	+$247K	﹤0.01%	3865

Other funds holding PMD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CIC

Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Bank of New York Mellon's PMD Position: Q3 2020 in Review

Bank of New York Mellon sold out of Psychemedics Corporation (PMD) in Q3 2020, closing a stake of 11,074 shares — an estimated $61K sold.

Bank of New York Mellon first reported a position in PMD in Q3 2017 and held it in 12 quarters. The position peaked at $859K in Q1 2018. 34 funds tracked by Wall St. Rank hold PMD as of Q3 2020.

Bank of New York Mellon reported no remaining Psychemedics Corporation position as of Q3 2020 after selling out during the quarter.
Bank of New York Mellon sold 11,074 Psychemedics Corporation shares in Q3 2020, an estimated $61K.
Bank of New York Mellon first reported a position in Psychemedics Corporation in Q3 2017 and held it in 12 quarters.
Bank of New York Mellon's Psychemedics Corporation position peaked at $859K in Q1 2018.
34 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q3 2020.

Based on Bank of New York Mellon's 13F filing for Q3 2020, filed 12 Nov 2020.